Eli Lilly (LLY) FCF Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,396.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-935.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
1,326.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
1,043.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
511.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
1,008.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
934.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-853.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
1,396.00 |
| Dec 31, 2025 |
-371.00 |
| Sep 30, 2025 |
1,770.00 |
| Jun 30, 2025 |
680.00 |
| Mar 31, 2025 |
-82.00 |
| Dec 31, 2024 |
2,201.00 |
| Sep 30, 2024 |
781.00 |
| Jun 30, 2024 |
341.00 |
| Mar 31, 2024 |
-1,321.00 |
| Dec 31, 2023 |
-3,070.00 |
| Sep 30, 2023 |
-1,021.00 |
| Jun 30, 2023 |
-1,380.00 |
| Mar 31, 2023 |
-1,237.00 |
| Dec 31, 2022 |
-872.00 |
| Sep 30, 2022 |
393.00 |
| Jun 30, 2022 |
-817.00 |
| Mar 31, 2022 |
710.00 |
| Dec 31, 2021 |
634.00 |
| Sep 30, 2021 |
-551.00 |
| Jun 30, 2021 |
-1,957.00 |
| Mar 31, 2021 |
1,841.00 |
| Dec 31, 2020 |
-849.00 |
| Sep 30, 2020 |
186.00 |
| Jun 30, 2020 |
2,586.00 |
| Mar 31, 2020 |
0.00 |
| Dec 31, 2019 |
807.00 |
| Sep 30, 2019 |
-1,213.00 |
| Jun 30, 2019 |
-723.00 |
| Mar 31, 2019 |
-192.00 |
| Dec 31, 2018 |
-240.00 |
| Sep 30, 2018 |
594.00 |
| Jun 30, 2018 |
-292.00 |
| Mar 31, 2018 |
76.00 |
| Dec 31, 2017 |
-662.00 |
| Sep 30, 2017 |
133.00 |
| Jun 30, 2017 |
315.00 |
| Mar 31, 2017 |
1,094.00 |
| Dec 31, 2016 |
1,626.00 |
| Sep 30, 2016 |
1,087.00 |
| Jun 30, 2016 |
684.00 |
| Mar 31, 2016 |
-179.00 |
| Dec 31, 2015 |
-870.00 |
| Sep 30, 2015 |
-1,184.00 |
| Jun 30, 2015 |
-163.00 |
| Mar 31, 2015 |
-739.00 |
| Dec 31, 2014 |
-159.00 |
| Sep 30, 2014 |
-150.00 |
| Jun 30, 2014 |
-912.00 |
| Mar 31, 2014 |
-245.00 |
| Dec 31, 2013 |
178.00 |
| Sep 30, 2013 |
508.00 |
| Jun 30, 2013 |
520.00 |
| Mar 31, 2013 |
-893.00 |
| Dec 31, 2012 |
-797.00 |
| Sep 30, 2012 |
-584.00 |
| Jun 30, 2012 |
-1,029.00 |
| Mar 31, 2012 |
-552.00 |
| Dec 31, 2011 |
-403.00 |
| Sep 30, 2011 |
180.00 |
| Jun 30, 2011 |
-104.00 |
| Mar 31, 2011 |
322.00 |
| Dec 31, 2010 |
227.00 |
| Sep 30, 2010 |
806.00 |
| Jun 30, 2010 |
1,734.00 |
| Mar 31, 2010 |
1,655.00 |
